ARTEMIS Trademark

Trademark Overview

On Wednesday, January 20, 2016, a trademark application was filed for ARTEMIS with the United States Patent and Trademark Office. The USPTO has given the ARTEMIS trademark a serial number of 86880860. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2019. This trademark is owned by Eureka Therapeutics, Inc.. The ARTEMIS trademark is filed in the Pharmaceutical Products category with the following description:

Biologics, namely, chimeric immune cell antigen receptors, namely, engineered immune cells made from an individual patient's immune cells and proprietary DNA, for therapeutic use for the treatment of cancers, for the treatment of proliferative cell diseases, and in transplantation
artemis

General Information

Serial Number86880860
Word MarkARTEMIS
Filing DateWednesday, January 20, 2016
Status700 - REGISTERED
Status DateTuesday, October 29, 2019
Registration Number5897433
Registration DateTuesday, October 29, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Goods and ServicesBiologics, namely, chimeric immune cell antigen receptors, namely, engineered immune cells made from an individual patient's immune cells and proprietary DNA, for therapeutic use for the treatment of cancers, for the treatment of proliferative cell diseases, and in transplantation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 25, 2016
Primary Code005
First Use Anywhere DateWednesday, July 31, 2019
First Use In Commerce DateWednesday, July 31, 2019

Trademark Owner History

Party NameEUREKA THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressEMERYVILLE, CA 94608
Party NameEureka Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameEureka Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameEureka Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Wednesday, May 11, 2016NON-FINAL ACTION WRITTEN
Wednesday, May 11, 2016NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 11, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 12, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 1, 2016FINAL REFUSAL E-MAILED
Thursday, December 1, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 2, 2017EX PARTE APPEAL-INSTITUTED
Saturday, January 23, 2016NEW APPLICATION ENTERED
Monday, January 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2016ASSIGNED TO EXAMINER
Thursday, December 1, 2016FINAL REFUSAL WRITTEN
Thursday, June 1, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 2, 2017EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, June 20, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, June 2, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, June 20, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, June 20, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 20, 2017ASSIGNED TO LIE
Tuesday, June 20, 2017EXAMINER'S AMENDMENT ENTERED
Saturday, July 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 1, 2017EXPARTE APPEAL TERMINATED
Thursday, March 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 29, 2018SOU EXTENSION 2 FILED
Wednesday, August 29, 2018SOU EXTENSION 2 GRANTED
Friday, August 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 26, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 27, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, March 27, 2018SOU EXTENSION 1 FILED
Tuesday, March 27, 2018SOU EXTENSION 1 GRANTED
Wednesday, August 29, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, March 26, 2019SOU EXTENSION 3 FILED
Tuesday, March 26, 2019SOU EXTENSION 3 GRANTED
Thursday, March 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2019TEAS STATEMENT OF USE RECEIVED
Friday, August 30, 2019USE AMENDMENT FILED
Saturday, September 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Saturday, September 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 23, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 24, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 29, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, April 29, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 29, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

artemis immune treatment cell cells namely proprietary therapeutic diseases transplantation patient